Home › Companies › Biotechnology, Health Care, Health Diagnostics, Manufacturing, Medical, Medical Device, Pharmaceutical, Product Research › Centrymed
Centrymed
Centrymed focuses on the field of tumor treatment, and its self-developed dual-antibody platform.
Operating in biotechnology, health care, health diagnostics, manufacturing, medical, medical device, pharmaceutical, product research based in Asia-Pacific (APAC), Centrymed was founded in 2017.
Centrymed is positioned in biotechnology, health care, health diagnostics, manufacturing, medical, medical device, pharmaceutical, product research, a segment that rewards a clear, focused offering.
The company is recorded as being based in Asia-Pacific (APAC).
Directory data places it at the Series_A stage.
Recorded headcount: c_00011_00050 employees.
| Sector | Biotechnology, Health Care, Health Diagnostics, Manufacturing, Medical, Medical Device, Pharmaceutical, Product Research |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2017 |
| Employees | c_00011_00050 |
| Stage | series_a |
Website: www.centrymed.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account